Track topics on Twitter Track topics that are important to you
Treeway has reported positive results from a Phase I clinical trial designed to analyse the bioavailability of TW001 in comparison...Read More... The post Treeway reports positive results in Phase I s...
Dutch biotech Treeway has completed its Phase I trial of lead program TW001, an oral formulation of edaravone, for the...
Following his own diagnosis with ALS in 2010, oil and shipping entrepreneur Bernard Muller co-founded Treeway, a biotechnology company with a mission to develop therapies to treat and cure the disease...
Treeway has obtained Phase I results showing its oral ALS treatment could be more effective than its injectable counterpart in targeting oxidative stress, which contributes to neuronal death in the di...
--Study suggests that novel oral formulation of edavarone improves bioavailability while remaining well tolerated-- Treeway, a biotech company developing therapies against amy...
SummaryTreeway BV Treeway is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis ALS. The company's pipeline products include TW001, an oral formulation of e...
We have published hundreds of Treeway news stories on BioPortfolio along with dozens of Treeway Clinical Trials and PubMed Articles about Treeway for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Treeway Companies in our database. You can also find out about relevant Treeway Drugs and Medications on this site too.